1. Home
  2. PD vs EMBC Comparison

PD vs EMBC Comparison

Compare PD & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$6.22

Market Cap

636.9M

Sector

Technology

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.84

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
EMBC
Founded
2009
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
636.9M
521.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PD
EMBC
Price
$6.22
$8.84
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
$12.63
$18.50
AVG Volume (30 Days)
3.0M
805.7K
Earning Date
03-12-2026
05-08-2026
Dividend Yield
N/A
6.79%
EPS Growth
416.95
20.90
EPS
1.87
0.74
Revenue
$492,546,000.00
N/A
Revenue This Year
$3.58
$1.17
Revenue Next Year
$1.65
N/A
P/E Ratio
$3.29
$11.95
Revenue Growth
5.36
N/A
52 Week Low
$5.92
$8.47
52 Week High
$18.51
$15.55

Technical Indicators

Market Signals
Indicator
PD
EMBC
Relative Strength Index (RSI) 32.27 39.76
Support Level $6.17 $8.72
Resistance Level $16.47 $9.47
Average True Range (ATR) 0.42 0.35
MACD -0.02 0.05
Stochastic Oscillator 17.37 39.20

Price Performance

Historical Comparison
PD
EMBC

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: